Literature DB >> 31475208

High Aβ load may cause microglial cell dysfunction and reduced nuclear repressor element-1 silencing transcription factor (REST) expression which might be ascribed to its degradation by ubiquitination.

Min Fang1, Yanxin Zhao1, Xueyuan Liu1.   

Abstract

BACKGROUND: This study aimed to investigate the effects of high Aβ load on the microglial function, neuronal activity, and repressor element-1 silencing transcription factor (REST) expression and nuclear localization and further explore the mechanism underlying nuclear REST deficiency and the correlation between pathology and symptoms in Alzheimer's disease (AD).
METHODS: BV2 cells and N2A cells were treated with Aβ at different concentrations, and the viability, apoptosis and autophagy of these cells were further evaluated. The expression of major histocompatibility complex class II (MHC-II, a marker of microglial activation), REST in the neurons and REST specific phosphorylase casein kinase 1 (CK1) were detected.
RESULTS: Aβ at a low concentration (2.5 µmol/L) could alter the microglial morphology, and the proportion of amoebic microglia and protein expression of MHC-II increased in a Aβ concentration dependent manner. Aβ at a high concentration (10 µmol/L) was able to reduce REST expression, elevate the expression of pro-apoptotic and pro-autophagic genes, inhibit the expression of anti-apoptotic gene, and reduce the neuronal activity. REST expression reduced, but CK1 increased in neurons, and CK1 inhibitor significantly increased REST expression. there was co-expression of REST and CK1 in the brain of AD mice, which was characterized by reduced nuclear REST expression and elevated CK1 expression.
CONCLUSIONS: High Aβ load may cause microglial cell dysfunction and loss of REST expression in the neurons, resulting in dementia. The reduced nuclear REST might be ascribed to its degradation by ubiquitination. This supports the hypothesis that high plaque load may increase the risk for dementia.

Entities:  

Keywords:  Alzheimer’s disease (AD); casein kinase 1 (CK1); cognitive function; microglia; repressor element-1 silencing transcription factor (REST)

Year:  2019        PMID: 31475208      PMCID: PMC6694275          DOI: 10.21037/atm.2019.06.73

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  11 in total

Review 1.  Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease.

Authors:  Antero Salminen; Kai Kaarniranta; Annakaisa Haapasalo; Mikko Hiltunen; Hilkka Soininen; Irina Alafuzoff
Journal:  Prog Neurobiol       Date:  2011-11-22       Impact factor: 11.685

Review 2.  Innate immunity and the etiology of late-onset Alzheimer's disease.

Authors:  Piet Eikelenboom; Erik van Exel; Rob Veerhuis; Annemieke J M Rozemuller; Willem A van Gool; Jeroen J M Hoozemans
Journal:  Neurodegener Dis       Date:  2012-01-17       Impact factor: 2.977

Review 3.  Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.

Authors:  Yu-Hui Liu; Fan Zeng; Ye-Ran Wang; Hua-Dong Zhou; Brian Giunta; Jun Tan; Yan-Jiang Wang
Journal:  Drug Discov Today       Date:  2013-08-13       Impact factor: 7.851

4.  Protective effects of NSAIDs on the development of Alzheimer disease.

Authors:  Steven C Vlad; Donald R Miller; Neil W Kowall; David T Felson
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

5.  Casein kinase 1 suppresses activation of REST in insulted hippocampal neurons and halts ischemia-induced neuronal death.

Authors:  Naoki Kaneko; Jee-Yeon Hwang; Michael Gertner; Fabrizio Pontarelli; R Suzanne Zukin
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

6.  Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death.

Authors:  Kyung-Min Noh; Jee-Yeon Hwang; Antonia Follenzi; Rodoniki Athanasiadou; Takahiro Miyawaki; John M Greally; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 7.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

Review 8.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

9.  Complement and microglia mediate early synapse loss in Alzheimer mouse models.

Authors:  Victoria F Beja-Glasser; Bianca M Nfonoyim; Soyon Hong; Arnaud Frouin; Shaomin Li; Saranya Ramakrishnan; Katherine M Merry; Qiaoqiao Shi; Arnon Rosenthal; Ben A Barres; Cynthia A Lemere; Dennis J Selkoe; Beth Stevens
Journal:  Science       Date:  2016-03-31       Impact factor: 47.728

10.  REST and stress resistance in ageing and Alzheimer's disease.

Authors:  Tao Lu; Liviu Aron; Joseph Zullo; Ying Pan; Haeyoung Kim; Yiwen Chen; Tun-Hsiang Yang; Hyun-Min Kim; Derek Drake; X Shirley Liu; David A Bennett; Monica P Colaiácovo; Bruce A Yankner
Journal:  Nature       Date:  2014-03-19       Impact factor: 49.962

View more
  3 in total

1.  Repressor element-1 silencing transcription factor regulates glutamate receptors and immediate early genes to affect synaptic plasticity.

Authors:  Chenhaoyi Xu; Min Zhang; Lu Zu; Pei Zhang; Letao Sun; Xueyuan Liu; Min Fang
Journal:  Aging (Albany NY)       Date:  2021-06-09       Impact factor: 5.682

2.  An Oligomannuronic Acid-Sialic Acid Conjugate Capable of Inhibiting Aβ42 Aggregation and Alleviating the Inflammatory Response of BV-2 Microglia.

Authors:  Jianrong Wu; Miaosen Wu; Hongtao Zhang; Xiaobei Zhan; Nian Wu
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

3.  Methyltransferase-Like 3 Rescues the Amyloid-beta protein-Induced Reduction of Activity-Regulated Cytoskeleton Associated Protein Expression via YTHDF1-Dependent N6-Methyladenosine Modification.

Authors:  Chenhaoyi Xu; Huanghuang Huang; Min Zhang; Pei Zhang; Zezhi Li; Xueyuan Liu; Min Fang
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.